//
Alan D. Brooks - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Roaa M. Kassim - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Paclitaxel
Karnika Singh - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
tetrandrine
Mpho Choene - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
camptothecin
Antony R. Chadderton - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Rituximab
Maryam Saffarian - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Myeong-Sun Kim - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Gemcitabine
Ibrahim O. Farah - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Central Nervous System (CNS)
Solid malignancies
Phosphatidylserine
Zhenyuan Tang - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Theresa Thekkudan - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
chloroquine
Yun-Fei Wen - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Hydroxychloroquine
Chih-Wen Shu - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Hydroxychloroquine
Alan K. Chiang - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Bortezomib
Theresa Thekkudan - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Ergocalciferol
Jiajing Cai - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Paclitaxel
Yaara Porat - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Min Zheng - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Rapacan
I P. Lin - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Metformin Hydrochloride
Taekyu Lee - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Susan Lee - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A